![Viral Lysates for Diagnostic Research](https://thenativeantigencompany.com/wp-content/uploads/2019/06/shutterstock_1124046443.jpg)
![Viral Lysates for Diagnostic Research](https://thenativeantigencompany.com/wp-content/uploads/2019/06/shutterstock_1124046443.jpg)
![Zika Prevalence in Suriname: Evidence for Zika Cross-Reactivity](https://thenativeantigencompany.com/wp-content/uploads/2019/02/shutterstock_444905509-2.jpg)
Zika Prevalence in Suriname: Evidence for Zika Cross-Reactivity
A recent study published by Langerak et al. tested for the seroprevalence of Zika virus in Suriname populations and evaluated the comparative effectiveness of using a commercial ELISA and a standard Virus Neutralisation Assay. Here we discuss the study, its results,...![Overcoming Zika-Dengue cross-reactivity: the highly specific immunoassays your lab needs](https://thenativeantigencompany.com/wp-content/uploads/2019/02/Zika-Virus-24-M.jpg)
Overcoming Zika-Dengue cross-reactivity: the highly specific immunoassays your lab needs
In the global battle against Zika virus, serological cross-reactivity with Dengue is a major challenge for academics, epidemiologists and pharmaceutical companies alike. Novel immunoassays can now overcome this problem and could prove a real game-changer in Zika...![Visualising viral infection with immunofluorescence microscopy](https://thenativeantigencompany.com/wp-content/uploads/2019/01/Figure-11-1-1020x675.jpg)
Visualising viral infection with immunofluorescence microscopy
Following the latest immunofluoresence data for our Zika and Dengue antibodies, we’ve invited VRS to write a short blog one of their areas of expertise: The applications of immunofluorescence microscopy in studying viruses. A lot of what we know about biology...![Five Methods You Can Use to Overcome Zika-Dengue Cross-Reactivity](https://thenativeantigencompany.com/wp-content/uploads/2018/12/Zika-Virus-8-M-3.jpg)